Seagen
Venture capital · Bothell, Washington, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
6Deep-tech portfolio0 active
6Portfolio exitsAcquired or listed
0Raises, 12 monthsLatest: Elevation Oncology
12Co-investorsShare a portfolio company
Portfolio · 6 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Elevation Oncology | Biotech | Acquired | Nov 18, 2020 | $70.5M |
| Silverback Therapeutics | Biotech | Acquired | Oct 6, 2020 | $139.3M |
| iTeos Therapeutics | Biotech | Acquired | Apr 9, 2020 | $125.4M |
| Mersana Therapeutics | Biotech | Acquired | Jun 24, 2016 | $69.2M |
| Immunomedics | Biotech | Acquired | — | — |
| Tubulis | Biotech | Acquired | — | — |
Peer ranks
Portfolio size#67
Portfolio exits#31
Raises, 12 months#88
Co-investors#150
Co-investors
- Atlas VentureVenture capital3 shared
- SR OneVenture capital2 shared
- Andera PartnersVenture capital1 shared
- Deep Track CapitalVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
- EQT Life SciencesVenture capital1 shared
- Frazier Healthcare PartnersVenture capital1 shared
- Gilead SciencesVenture capital1 shared
- GVVenture capital1 shared
- MPM CapitalVenture capital1 shared
Sectors
- Biotech6
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.